SCHEMBL29485914

SCHEMBL29485914

Clc1ccc2c(c1)N(CC1CO1)c1ccccc1CC2

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 3/20 0.54
▸ KMT2A Q03164 3/20 0.54
▸ TP53 P04637 2/20 0.54
▸ CYP3A4 P08684 2/20 0.54
▸ CYP1A2 P05177 2/20 0.54
▸ SLC22A1 O15245 1/20 0.54
▸ ABCB11 O95342 1/20 0.54
▸ ADRB2 P07550 1/20 0.54
▸ CHRM2 P08172 1/20 0.54
▸ CHRM4 P08173 1/20 0.54
▸ ADRB1 P08588 1/20 0.54
▸ HTR1A P08908 1/20 0.54
▸ CHRM5 P08912 1/20 0.54
▸ ADRA2A P08913 1/20 0.54
▸ ADORA3 P0DMS8 1/20 0.54
▸ CYP2D6 P10635 1/20 0.54
▸ CHRM1 P11229 1/20 0.54
▸ DRD2 P14416 1/20 0.54
▸ TSHR P16473 1/20 0.54
▸ ADRA2B P18089 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14707071 1.00 MEN1 (0.54) MEN1KMT2ATP53CYP3A4CYP1A2
SCHEMBL14707083 0.87 HTR2A (0.47) MEN1KMT2ACYP3A4CYP1A2SLC22A1
SCHEMBL7167351 0.87 HTR2A (0.47) MEN1KMT2ACYP3A4CYP1A2SLC22A1
SCHEMBL14707008 0.87 HTR2A (0.47) MEN1KMT2ACYP3A4CYP1A2SLC22A1
SCHEMBL11681069 0.83 SLC6A2 (0.46) MEN1KMT2ATP53CYP3A4CYP1A2
SCHEMBL11678606 0.82 MEN1 (0.51) MEN1KMT2ATP53CYP3A4CYP1A2
SCHEMBL11680286 0.79 DRD4 (0.54) MEN1KMT2ATP53CYP3A4CYP1A2
SCHEMBL15981159 0.77 DHFR (0.41) TP53HTR1AADRA2ADRD2ADRA2C
SCHEMBL4669145 0.75 CYP3A4 (0.65) MEN1KMT2ATP53CYP3A4CYP1A2
SCHEMBL6963908 0.74 HTR2A (0.71) MEN1KMT2ATP53CYP3A4CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3976185-A1 HECT E3 LIGASE INHIBITORS AND USES THEREOF IFOM - Fondazione Istituto FIRC di Oncologia Molecolare (IT) 2022-04-06 — — EP disclosed
Send feedback